[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Feldman Cardiology, PLLC\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":36},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":4,"overallStatus":24,"whyStopped":4,"lastUpdateSubmitDate":25,"lastUpdatePostDateStruct":26,"startDateStruct":29,"completionDateStruct":31,"leadSponsor":33,"locationsCount":4},"100631388","categorizing-patient-risk-for-tricuspid-regurgitation-tr-intervention-with-admittance-pulmonary-artery-catheter-system-apacs-100631388",false,"NCT07500025","Categorizing Patient Risk for Tricuspid Regurgitation (TR) Intervention With Admittance Pulmonary Artery Catheter System (APACS)","Inclusion Criteria:\n\n* Patients with severe or torrential TR who are already scheduled to undergo clinically indicated tricuspid valve (TV) percutaneous replacement or clipping to reduce heart failure symptoms\n\nExclusion Criteria:\n\n* Children (defined as individual \\\u003C18 years of age) will be excluded from this study","ALL","18 Years",{"count":18,"type":19},8,"ESTIMATED","OBSERVATIONAL","The study is focused on evaluation of the effectiveness of the Admittance Pulmonary Artery Catheter (PAC) system for assessing the right ventricular (RV) function in patients with tricuspid regurgitation (TR) prior to tricuspid valve intervention.",[23],"Tricuspid Regurgitation (TR)","NOT_YET_RECRUITING","2026-03-24",{"date":27,"type":28},"2026-03-30","ACTUAL",{"date":30,"type":19},"2027-07-10",{"date":32,"type":19},"2028-07-10",{"name":34,"class":35},"Feldman Cardiology, PLLC","OTHER",""]